The Potential Role of Genomic Medicine in the Therapeutic Management of Rheumatoid Arthritis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Potential Role of Genomic Medicine in the Therapeutic Management of Rheumatoid Arthritis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 6, Pages 826
Publisher
MDPI AG
Online
2019-06-10
DOI
10.3390/jcm8060826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
- (2019) Aida Ferreiro-Iglesias et al. PLoS One
- Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39
- (2019) Athina Spiliopoulou et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis
- (2018) Rosario López-Rodríguez et al. PHARMACOGENOMICS JOURNAL
- Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients
- (2018) John C. Taylor et al. PHARMACOGENOMICS JOURNAL
- Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus
- (2018) David González-Serna et al. Scientific Reports
- Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis
- (2018) Jonathan Massey et al. PHARMACOGENOMICS JOURNAL
- Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases
- (2018) Marialbert Acosta-Herrera et al. ANNALS OF THE RHEUMATIC DISEASES
- Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations
- (2018) Ana Márquez et al. Genome Medicine
- Novel treatment strategies in rheumatoid arthritis
- (2017) Gerd R Burmester et al. LANCET
- The Histone Modification Code in the Pathogenesis of Autoimmune Diseases
- (2017) Yasuto Araki et al. MEDIATORS OF INFLAMMATION
- Genetic architecture: the shape of the genetic contribution to human traits and disease
- (2017) Nicholas J. Timpson et al. NATURE REVIEWS GENETICS
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis
- (2017) S Bek et al. PHARMACOGENOMICS JOURNAL
- Precision Medicine in Rheumatoid Arthritis
- (2017) James Bluett et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment
- (2017) Bart V. J. Cuppen et al. RHEUMATOLOGY INTERNATIONAL
- Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis
- (2017) Jing Cui et al. Arthritis & Rheumatology
- A combined large-scale meta-analysis identifiesCOG6as a novel shared risklocusfor rheumatoid arthritis and systemic lupus erythematosus
- (2016) Ana Márquez et al. ANNALS OF THE RHEUMATIC DISEASES
- Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritis
- (2016) Bruno Stuhlmüller et al. CLINICAL IMMUNOLOGY
- The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis
- (2016) XiaoBing Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps
- (2016) Valentina Iotchkova et al. NATURE GENETICS
- Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
- (2016) David Ellinghaus et al. NATURE GENETICS
- Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis
- (2016) Young Ho Lee et al. RHEUMATOLOGY INTERNATIONAL
- Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis
- (2016) Solveig K. Sieberts et al. Nature Communications
- Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
- (2016) Elena López-Isac et al. Arthritis & Rheumatology
- Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis
- (2016) Darren Plant et al. Arthritis & Rheumatology
- Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy
- (2015) M. Iwaszko et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Association of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response
- (2015) Sebastien Viatte et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases
- (2015) Yun R Li et al. NATURE MEDICINE
- Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs
- (2015) Luz M. Canet et al. Pharmacogenetics and Genomics
- Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
- (2015) A Ferreiro-Iglesias et al. PHARMACOGENOMICS JOURNAL
- Successful Treatment of Animal Models of Rheumatoid Arthritis with Small-Molecule Cyclin-Dependent Kinase Inhibitors
- (2014) C. Sekine et al. JOURNAL OF IMMUNOLOGY
- The BAFF/APRIL system in SLE pathogenesis
- (2014) Fabien B. Vincent et al. Nature Reviews Rheumatology
- Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation
- (2014) Sabyasachi Senapati et al. Pharmacogenetics and Genomics
- Targeted exon sequencing fails to identify rare coding variants with large effect in rheumatoid arthritis
- (2014) So-Young Bang et al. ARTHRITIS RESEARCH & THERAPY
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Genetics of Rheumatoid Arthritis — A Comprehensive Review
- (2013) Júlia Kurkó et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Genetics of rheumatoid arthritis contributes to biology and drug discovery
- (2013) Yukinori Okada et al. NATURE
- Clinical implications of shared genetics and pathogenesis in autoimmune diseases
- (2013) Alexandra Zhernakova et al. Nature Reviews Endocrinology
- GWAS replication study confirms the association of PDE3A–SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis
- (2013) Isabel Acosta-Colman et al. PHARMACOGENOMICS
- Rare, Low-Frequency, and Common Variants in the Protein-Coding Sequence of Biological Candidate Genes from GWASs Contribute to Risk of Rheumatoid Arthritis
- (2012) Dorothée Diogo et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis
- (2012) Sophine B. Krintel et al. Pharmacogenetics and Genomics
- Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure
- (2012) Jaap Fransen et al. PHARMACOGENOMICS
- Examining the overlap between genome-wide rare variant association signals and linkage peaks in rheumatoid arthritis
- (2011) S. Eyre et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort
- (2011) Darren Plant et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Unknown
- (2011) Ning Wang et al. MOLECULAR MEDICINE
- MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms
- (2011) S A Owen et al. PHARMACOGENOMICS JOURNAL
- Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients
- (2010) L. R. Coulthard et al. ANNALS OF THE RHEUMATIC DISEASES
- Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
- (2010) Eli A Stahl et al. NATURE GENETICS
- The effect ofESR1andESR2gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide
- (2010) Violetta Dziedziejko et al. PHARMACOGENOMICS
- Optimalisation of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond
- (2009) W M Kooloos et al. ANNALS OF THE RHEUMATIC DISEASES
- Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
- (2009) Merete Lund Hetland et al. ARTHRITIS AND RHEUMATISM
- Inhibition of PCSK9 as a novel strategy for the treatment of hypercholesterolemia
- (2009) D. Lopez DRUG NEWS & PERSPECTIVES
- Common and different genetic background for rheumatoid arthritis and coeliac disease
- (2009) Marieke J.H. Coenen et al. HUMAN MOLECULAR GENETICS
- Finding the missing heritability of complex diseases
- (2009) Teri A. Manolio et al. NATURE
- Lp(a) Lipoprotein Redux — From Curious Molecule to Causal Risk Factor
- (2009) Sekar Kathiresan NEW ENGLAND JOURNAL OF MEDICINE
- The effect of exon (19C>A) dihydroorotate dehydrogenase gene polymorphism on rheumatoid arthritis treatment with leflunomide
- (2009) Andrzej Pawlik et al. PHARMACOGENOMICS
- Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levels
- (2009) D. Steinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?
- (2008) S L Hider et al. ANNALS OF THE RHEUMATIC DISEASES
- Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients
- (2008) Petra Bohanec Grabar et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Detecting shared pathogenesis from the shared genetics of immune-related diseases
- (2008) Alexandra Zhernakova et al. NATURE REVIEWS GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started